4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid has been researched along with Body Weight in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, L; Friedlos, F; Marais, R; Martin, J; Spooner, RA; Springer, CJ; Stribbling, SM | 1 |
1 other study(ies) available for 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid and Body Weight
Article | Year |
---|---|
Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effect.
Topics: Animals; Antineoplastic Agents; Apoptosis; Body Weight; Breast Neoplasms; Female; gamma-Glutamyl Hydrolase; Genetic Therapy; Glutamates; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Nitrogen Mustard Compounds; Prodrugs; Time Factors | 2000 |